Allocating recycled significance levels in group sequential procedures for multiple endpoints

被引:19
作者
Xi, Dong [1 ]
Tamhane, Ajit C. [2 ]
机构
[1] Novartis Pharmaceut, IIS Stat Methodol, E Hanover, NJ 07936 USA
[2] Northwestern Univ, Dept Ind Engn & Management Sci, Evanston, IL 60208 USA
关键词
Error spending function; Familywise error rate; Graphical approach; O'Brien-Fleming boundary; Pocock boundary; Recycling; CLINICAL-TRIALS; ADAPTIVE EXTENSIONS; DESIGN;
D O I
10.1002/bimj.201300157
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Graphical approaches have been proposed in the literature for testing hypotheses on multiple endpoints by recycling significance levels from rejected hypotheses to unrejected ones. Recently, they have been extended to group sequential procedures (GSPs). Our focus in this paper is on the allocation of recycled significance levels from rejected hypotheses to the stages of the GSPs for unrejected hypotheses. We propose a delayed recycling method that allocates the recycled significance level from Stage r onward, where r is prespecified. We show that r cannot be chosen adaptively to coincide with the random stage at which the hypothesis from which the significance level is recycled is rejected. Such an adaptive GSP does not always control the FWER. One can choose r to minimize the expected sample size for a given power requirement. We illustrate how a simulation approach can be used for this purpose. Several examples, including a clinical trial example, are given to illustrate the proposed procedure.
引用
收藏
页码:90 / 107
页数:18
相关论文
共 39 条
[31]   A group sequential type design for three-arm non-inferiority trials with binary endpoints [J].
Li, Gang ;
Gao, Shan .
BIOMETRICAL JOURNAL, 2010, 52 (04) :504-518
[32]   ON ADAPTIVE ERROR SPENDING APPROACH FOR GROUP SEQUENTIAL TRIALS WITH RANDOM INFORMATION LEVELS [J].
Liu, Qing ;
Lim, Pilar ;
Nuamah, Issac ;
Li, Yulan .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2012, 22 (04) :687-699
[33]   A parametric multiple test procedure to adaptive group-sequential trials allowing for mid-term modifications [J].
Jin, Man .
CONTEMPORARY CLINICAL TRIALS, 2020, 90
[34]   Statistical Testing of Single and Multiple Endpoint Hypotheses in Group Sequential Clinical Trials [J].
Huque, Mohammad ;
Mushti, Sirisha ;
Alosh, Mohamed .
BIOPHARMACEUTICAL APPLIED STATISTICS SYMPOSIUM, VOL 3: PHARMACEUTICAL APPLICATIONS, 2018, :119-149
[35]   Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary Outcomes [J].
Hamasaki, Toshimitsu ;
Asakura, Koko ;
Evans, Scott R. ;
Sugimoto, Tomoyuki ;
Sozu, Takashi .
STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2015, 7 (01) :36-54
[36]   Simultaneous population enrichment and endpoint selection in phase 3 randomized controlled trials: An adaptive group sequential design with two binary alternative primary endpoints [J].
Sinha, Arup K. ;
Moye III, Lemuel ;
Piller, Linda B. ;
Yamal, Jose-Miguel ;
Barcenas, Carlos H. ;
Song, Jaejoon ;
Davis, Barry R. .
COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 2024, 53 (10) :3728-3741
[37]   Bayesian methods to compare dose levels with placebo in a small n, sequential, multiple assignment, randomized trial [J].
Fang, Fang ;
Hochstedler, Kimberly A. ;
Tamura, Roy N. ;
Braun, Thomas M. ;
Kidwell, Kelley M. .
STATISTICS IN MEDICINE, 2021, 40 (04) :963-977
[38]   Comparing Dose Levels to Placebo using a Continuous Outcome in a Small n, Sequential, Multiple Assignment, Randomized trial (snSMART) [J].
Fang, Fang ;
Tamura, RoyN ;
Braun, Thomas M. ;
Kidwell, Kelley M. .
STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (03) :502-509
[39]   An 8-Week, Randomized, Phase 2, Double-Blind, Sequential Parallel-Group Comparison Study of Two Dose Levels of the GABAA Positive Allosteric Modulator PF-06372865 Compared With Placebo as an Adjunctive Treatment in Outpatients With Inadequate Response to Standard of Care for Generalized Anxiety Disorder [J].
Simen, Arthur ;
Whitlock, Mark ;
Qiu, Ruolun ;
Miceli, Jeff ;
Zumpano, Laura ;
Du Metz, Michaele ;
Dua, Pinky ;
Binneman, Brendon .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (01) :20-27